The burden of RSV, hMPV, and PIV amongst hospitalized adults in the United States from 2016 to 2019
Journal of Hospital Medicine · 2024-07 · 19 (7) · 581-588
DOI: 10.1002/jhm.13320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Medicine, online erschienen am 10.03.2024. Verfasst von Ajay Bhasin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hospital Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Metapneumovirus, Paramyxoviridae Infections, Hospitalization. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and parainfluenza virus (PIV) hospitalize many people yearly. Though severe lower respiratory tract disease has been described in children, the elderly, and the immunocompromised, there is a gap in our understanding of RSV, hMPV, and PIV in hospitalized adults. We sought to evaluate the association of RSV, hMPV, and PIV with severe respiratory disease requiring noninvasive or mechanical ventilation and death in hospitalized adults in the United States.
Methods
We conducted a retrospective, pooled, cross‐sectional study of general medicine hospitalizations in the United States from 2016 to 2019 using the National Inpatient Sample published by the Agency for Healthcare Quality and Research. We used multivariable Poisson regression to estimate the likelihood of severe respiratory disease or death. We used linear regression to estimate the mean difference in length of stay for those hospitalized with and without a respiratory virus.
Results
We found that RSV (incidence rate ratio [IRR]: 1.68, 95% confidence interval [CI]: 1.61–1.74, p < .001), hMPV (IRR: 1.82, 95% CI: 1.71–1.93, p < .001), and PIV (IRR: 1.81, 95% CI: 1.68–1.94, p < .001) were independently associated with severe respiratory disease, even after adjustment. Additionally, we found the presence of a respiratory virus prolonged hospitalizations by (0.79 ± 0.27 days, p < .003) for RSV, (0.88 ± 0.28 days, p < .002) for hMPV, and (1.43 ± 0.30 days, p < .001) for PIV.
Conclusions
RSV, hMPV, and PIV have a significant burden on hospitalized adults, even without classic risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Division of Hospital Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Pediatrics, Division of Hospital-Based Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, Rush Medical College, Chicago, Illinois, USA.
- Department of Medicine, Division of Infectious Diseases, Rush Medical College, Chicago, Illinois, USA.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Medicine, Division of Infectious Diseases, University of California, Irvine, California, USA.
ORCID-Profile: Ajay Bhasin, David C Nguyen
Zitieren
APA
Bhasin, A., Nguyen, D. C., Briggs, B. J., & Nam, H. H. (2024). The burden of RSV, hMPV, and PIV amongst hospitalized adults in the United States from 2016 to 2019. Journal of Hospital Medicine, 19(7), 581-588. https://doi.org/10.1002/jhm.13320
Vancouver
Bhasin A, Nguyen DC, Briggs BJ, Nam HH. The burden of RSV, hMPV, and PIV amongst hospitalized adults in the United States from 2016 to 2019. Journal of Hospital Medicine. 2024;19(7):581-588. doi:10.1002/jhm.13320
BibTeX
@article{Bhasin2024,
author = {Bhasin, Ajay and Nguyen, David C and Briggs, Benjamin J and Nam, Hannah H},
title = {The burden of RSV, hMPV, and PIV amongst hospitalized adults in the United States from 2016 to 2019},
journal = {Journal of Hospital Medicine},
year = {2024},
volume = {19},
number = {7},
pages = {581--588},
doi = {10.1002/jhm.13320}
}
EUVIMED